Vivanza Biosciences informs about disclosure

15 Nov 2022 Evaluate
Vivanza Biosciences has informed that pursuant to regulation 15(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the provisions of Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, is not applicable to the Company as the Paid Up Share Capital is less than Rs 10 Crores and Net Worth of the Company is less than Rs 25 Crores as on March 31st, 2022. As per Regulation 15(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the compliance with the Corporate Governance provisions as specified in Regulations 17, 17A, 18, 19, 20, 21, 22, 23, 24, 24A, 25, 26, 27 and clauses (b) to (i) and (t) of sub regulation (2) of Regulation 46 and Para C, D and E of Schedule V shall not apply. Hence, the Company is not required to submit 'Disclosures of the Related Party Transaction' as per Regulation 23(9) of SEBI (LODR) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Vivanza Biosciences Share Price

7.53 0.34 (4.73%)
16-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Adani Enterprises 3040.90
Redington 213.50
Amrapali Industries 14.74
Rashi Peripheral 329.85
Compuage Infocom 4.36
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.